0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Is pre‐heat necessary for the measurement of 8‐oxo‐7,8‐dihydroguanosine and 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine in urine samples

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          It is currently unclear for the necessary of pre‐heating urine samples for the accurate determination of 8‐oxo‐7,8‐dihydroguanosine (8‐oxoG) and 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG). Thus, we conducted this study to evaluate the effect of pre‐heat (i.e., to 37°C) on the accurate measurement of 8‐oxoG and 8‐oxodG in frozen urine samples.

          Methods

          Random urine samples from six healthy volunteers, six patients with renal dysfunction, and six patients with systematic diseases such as diabetes were collected, split, and stored at −80°C for up to 1 month. The frozen samples were thawed at room temperature (RT) or 37°C for different time, 10‐fold diluted with ddH2O containing 1% formic acid, and determined by self‐established LC–MS/MS method coupled with an ACQUITY™ Primer HSS T3 column.

          Results

          Thawing the samples at RT for 30 or 120 min, or at 37°C for 15 or 90 min did not affect the determination of 8‐oxoG and 8‐oxodG in urine samples. Moreover, no significant difference between thawing the urine samples at RT and 37°C was found after storing at −80°C for 1–3 months.

          Conclusion

          It is not always necessary to pre‐heat the frozen urine samples to release 8‐oxoG and 8‐oxodG from precipitates, which is associated with different pre‐treatment and determination methods.

          Abstract

          For both apparently healthy volunteers and patients with kidney dysfunction or other systematic diseases, no significant difference between thawing the frozen urine samples at RT and 37°C was found for the accurate determinations of urinary 8‐oxoG and 8‐oxodG with this pre‐treatment and determination method.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine.

          Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) is a widely used biomarker of oxidative stress. However, variability between chromatographic and ELISA methods hampers interpretation of data, and this variability may increase should urine composition differ between individuals, leading to assay interference. Furthermore, optimal urine sampling conditions are not well defined. We performed inter-laboratory comparisons of 8-oxodG measurement between mass spectrometric-, electrochemical- and ELISA-based methods, using common within-technique calibrants to analyze 8-oxodG-spiked phosphate-buffered saline and urine samples. We also investigated human subject- and sample collection-related variables, as potential sources of variability.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress.

            Of the DNA-derived biomarkers of oxidative stress, urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) is the most frequently measured. However, there is significant discrepancy between chromatographic and immunoassay approaches, and intratechnique agreement among all available chromatography-based assays and ELISAs is yet to be established. This is a significant obstacle to their use in large molecular epidemiological studies. To evaluate the accuracy of intra/intertechnique and interlaboratory measurements, samples of phosphate buffered saline and urine, spiked with different concentrations of 8-oxoG, together with a series of urine samples from healthy individuals were distributed to ESCULA members. All laboratories received identical samples, including 2 negative controls that contained no added 8-oxodG. Data were returned from 17 laboratories, representing 20 methods, broadly classified as mass spectrometric (MS), electrochemical detection (EC), or enzyme-linked immunosorbant assay (ELISA). Overall, there was good within-technique agreement, with the majority of laboratories' results lying within 1 sd of their consensus mean. However, ELISA showed more within-technique variation than did the chromatographic techniques and, for the urine samples, reported higher values. Bland-Altman plots revealed good agreement between MS and EC methods but concentration-dependent deviation for ELISA. All methods ranked urine samples according to concentration similarly. Creatinine levels are routinely used as a correction factor for urine concentration, and therefore we also conducted an interlaboratory comparison of methods for urinary creatinine determination, in which the vast majority of values lay within 1 sd of the consensus value, irrespective of the analysis procedure. This study reveals greater consensus than previously expected, although concern remains over ELISA.-ESCULA [European Standards Committee on Urinary (DNA) Lesion Analysis], Evans, M. D., Olinski, R., Loft, S., Cooke, M. S. Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2'-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry.

              The potential use of oxidative stress-induced DNA and RNA damage products as biomarkers is an important aspect of biomedical research. There is a need for assays with high specificity and sensitivity that also can be used in molecular epidemiology studies with a large number of subjects. In addition there is a need for assays that can measure more than one product from DNA oxidation. We present a sensitive, precise, and accurate method for quantitative analysis of the oxidized nucleosides 8-oxoGuo and 8-oxodG in human urine. The assay is based on automated sample handling using a BIOMEK 3000 Workstation, and UPLC-ESI(+)-MS/MS analysis. High specificity is evidenced by the use of qualifier ions for both analytes. The quantification limit in urine samples is 1 nM for both analytes. Accuracy and precision were documented, showing average recoveries of 106.2% (8-oxoGuo) and 106.9% (8-oxodG), and overall precision (within-day and between-days) of 6.1 and 4.4%, respectively.
                Bookmark

                Author and article information

                Contributors
                yusonglinpku@163.com
                lingqiubj@163.com
                Journal
                J Clin Lab Anal
                J Clin Lab Anal
                10.1002/(ISSN)1098-2825
                JCLA
                Journal of Clinical Laboratory Analysis
                John Wiley and Sons Inc. (Hoboken )
                0887-8013
                1098-2825
                29 August 2022
                October 2022
                : 36
                : 10 ( doiID: 10.1002/jcla.v36.10 )
                : e24674
                Affiliations
                [ 1 ] Department of Laboratory Medicine, Peking Union Medical College Hospital Peking Union Medical College & Chinese Academy of Medical Sciences Beijing China
                [ 2 ] Medical Science Research Center, Peking Union Medical College Hospital Peking Union Medical College & Chinese Academy of Medical Sciences Beijing China
                [ 3 ] State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Peking Union Medical College & Chinese Academy of Medical Sciences Beijing China
                Author notes
                [*] [* ] Correspondence

                Songlin Yu, Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifu Yuan, Dongcheng District, Beijing 100730, China.

                Email: yusonglinpku@ 123456163.com

                Ling Qiu, Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifu Yuan, Dongcheng District, Beijing 100730, China

                Email: lingqiubj@ 123456163.com

                Author information
                https://orcid.org/0000-0002-0734-8144
                Article
                JCLA24674 JCLA-22-1790.R1
                10.1002/jcla.24674
                9550956
                36036744
                820ff84e-c137-4063-a455-b48707227271
                © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 21 July 2022
                : 19 June 2022
                : 14 August 2022
                Page count
                Figures: 3, Tables: 0, Pages: 5, Words: 2865
                Funding
                Funded by: National Key Research and Development Program of China , doi 10.13039/501100012166;
                Award ID: 2021YF2009300/2021YF2009302
                Funded by: National High Level Hospital Clinical Research Funding
                Award ID: 2022‐PUMCH‐A‐138
                Funded by: Beijing Key Clinical Specialty for Laboratory Medicine‐Excellent Project
                Award ID: ZK201000
                Categories
                Brief Report
                Brief Report
                Custom metadata
                2.0
                October 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.0 mode:remove_FC converted:11.10.2022

                Clinical chemistry
                8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine,8‐oxo‐7,8‐dihydroguanosine,lc–ms/ms,pre‐heat

                Comments

                Comment on this article